MARKET WIRE NEWS
  1. Home
  2. Stock
  3. RARE
  4. News
RARE
Quote
Short
News
Articles
Message Board

Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE ) News

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) News Releases

RARE News Releases
RARE : NASDAQ
PR Newswire
LEVI & KORSINSKY, LLP: MANAGEMENT CONFIDENCE REPRESENTATIONS CHALLENGED IN ULTRAGENYX PHARMACEUTICAL SECURITIES ACTION
RARE : NASDAQ
GlobeNewswire
Ultragenyx to Participate at Investor Conferences in March
RARE : NASDAQ
SeekingAlpha
Rare disease pharmas could benefit from FDA guidance to accelerate development
RARE : NASDAQ
SeekingAlpha
Ultragenyx granted FDA priority review for rare metabolic disorder gene therapy
RARE : NASDAQ
GlobeNewswire
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
RARE : NASDAQ
SeekingAlpha
PTC Therapeutics: Sephience As A Major Growth Driver
RARE : NASDAQ
SeekingAlpha
Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call Transcript
RARE : NASDAQ
SeekingAlpha
Ultragenyx falls as guidance trails consensus amid job cuts
RARE : NASDAQ
Motley Fool
Ultragenyx (RARE) Q4 2025 Earnings Call Transcript
RARE : NASDAQ
SeekingAlpha
Ultragenyx Pharmaceutical GAAP EPS of -$1.29 misses by $0.16, revenue of $207M beats by $5.14M

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.